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ABSTRACT
Introduction: To determine the quality of life (physical health, psychological, social relationships and environment 
domains) among cancer patients undergoing chemotherapy in government hospitals in Peninsular Malaysia. Meth-
ods: The data were collected using self-administered questionnaires. Descriptive statistics were conducted to obtain 
frequency and percentage of variables. Independent sample T-test and One way ANOVA were used to determine 
the association between variables. Multiple linear regression model was used to determine the significant predictors. 
The predictors of each domain was analysed separately.   Results: Quality of life among cancer patients undergo-
ing chemotherapy in this study was determined by four domains which were physical health, psychological, social 
relationships and environment. The overall mean score for physical health was 52.60, psychological was 52.55, 
social relationships was 50.79 and environment was 51.16. The significant predictors of physical effect domain were 
monthly income, cancer stage, social support, nausea and vomiting. The significant predictors of psychological do-
main were race, marital status, cancer stage, nausea and vomiting. The significant predictors of social relationships 
domain were race, educational level, social support, nausea and vomiting. The significant predictors of environment 
domain were race, marital status, hopelessness level, nausea and vomiting.  Conclusion: The quality of life among 
chemotherapy cancer patients is important to be observed. Based on the predictors found in this study, appropriate 
interventions can be taken to improve the quality of life outcomes and the response towards the treatment.
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INTRODUCTION
Cancer is an important health concern at the global level 
as some new fourteen million cases were registered 
in 2012, thus emerging as one of the top reasons for 
the escalating rates of mortality and morbidity at the 
global scale (1). In 2015, cancer was responsible for 
8.8 million deaths making it the second leading cause 
of death globally (2). Based on a Malaysian National 
Cancer Registry (MNCR) report a whopping 103,507 is 
the number of established new cases of cancer between 
2007 and 2011 in Malaysia. This is made up of 46,794 
(45.2%) in males and 56,713 (54.8%) in females and 
1 in every 10 males is prone to get cancer while the 
probability in female is 1 in 9 (3). According to a report 
by The Star, death from cancer has increased from 
20100 in 2008 to 21700 in 2012. By 2025, occurrence 
of cancer related deaths in less developed areas is 
expected to increase by 80%. Cancer related deaths are 
rising tremendously due to factors such as smoking and 
tobacco use, poor diet, alcohol, lack of exercise or being 
overweight (2). The main cause of fatality among most 
females and males in Malaysia diagnosed with cancer 
has been breast cancer and colon cancers respectively 
(4). Patients’ quality of life can be impacted largely by 
diagnosis as well as treatment for cancer. The basic 
treatments for cancer can be: local treatments of surgery, 
radiotherapy, systemic treatments using biological agents 
(for example hormones, antibodies and growth factors) 
and chemotherapy (4). Chemotherapy, which appears 
to be a treatment that plays a vital role in mitigating 
cancer, can be carried out in isolation or combined 
with other treatments, such as radiotherapy and surgery. 
Chemotherapy side effects can worsen quality of life in 
cancer patients (5). Nevertheless, it is also the treatment 
that can improve quality of life in cancer patients (6). 
The effectiveness of a certain treatment for cancer can 
be determined by looking into quality of life, which 
reflects the measure of one’s primary end-point, which 
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also reflects patient’s opinion about the effect of cancer 
diagnosis and treatment on daily living (7). Study on 
the quality of life conducted among chemotherapy 
cancer patients showed that chemotherapy treatment 
highly affects the quality of life among cancer patients 
compared to patients undergoing other treatments. 
Thus it is important to evaluate the quality of life in 
chemotherapy cancer patients progressively. This 
study will be a baseline study for future research to 
enhance our understanding of the relationship between 
chemotherapy cancer treatment and how it is affecting 
patient’s quality of life.
MATERIALS AND METHODS
Study Design and Setting
A cross sectional study was conducted between April 
2016 and April 2017 with a total of 1333 chemotherapy 
cancer patients. Probability proportionate to size 
technique was used to determine the sample size 
from each hospital. Patients were recruited from ten 
state government hospitals in Peninsular Malaysia. 
The chemotherapy cancer patients list was obtained 
from Cytotoxic Drug Reconstitution (CDR) unit. 
Malaysian cancer patients above 18 years old that were 
undergoing chemotherapy were selected from the ten 
state hospitals to be included in this study. Patients with 
communication problems and extremely ill patients 
were excluded. Chemotherapy cancer patients attending 
the Daycare center and in-patients from oncology wards 
who consented to participate in this study were each 
given the self-administered questionnaire consisted 
of socio demographic characteristics, World Health 
Organization (WHO) Quality of Life-BREF WHOBREF, 
Multidimensional Scale of Perceived Social Support 
(MSPSS), The Beck Hopelessness Scale (BHS) and 
Common Terminology Criteria for Adverse Events 
(CTCAE) version 4.0. 
Study tool
The data were collected using four questionnaires:
WHOQOL-BREF questionnaire was used to determine 
the quality of life level encountered by each patient.  This 
questionnaire consist of 26 questions, being two about 
quality of life in general and the other 24 representing 
each of the facets that make up the original instrument. 
WHOQOL-BREF was chosen as because it comprises 
the element of physical health, psychological, social 
relationships and environment elements. The score of 
each question ranges from one to five and higher scores 
indicate a better evaluation.
The 12-item Multidimensional scale of perceived social 
support (MSPSS) was designed to measure the social 
support received from the three subscales family, friends, 
and significant other. This 12 items questionnaire 
measures perception from receiving support from family 
members (4 items), friends (4 items) and significant 
others (4 items).  All the items in this questionnaire are 
based on a scale from ‘totally agree’ to totally disagree’. 
A high score means a high level of perceived social 
support.
The Beck Hopelessness Scale (BHS) consist of the 20-
item Beck Hopelessness Scale (BHS). This questionnaire 
measures the level of negative attitude (pessimism) 
regarding the future life of the participants by employing 
a ‘0 to 20’ scale; in which ‘0 until 3’ is ‘normal’, 
‘4 until 8’ as ‘mild hopelessness’, ‘9 until 14’ for 
‘moderate hopelessness’, and ’15 and above’ for ‘severe 
hopelessness’.
Common Terminology Criteria for Adverse Events 
(CTCAE) version 4.0 questionnaire was used which 
includes nausea, vomiting, anorexia, diarrhea, 
constipation, anemia, fever, fatigue, infection, bleeding, 
hair loss, mouth, gum and throat infection also skin 
and nail changes.  The participants were requested to 
mark ‘X’ for the following scale: ‘0’ for ‘none’, ‘1’ for 
‘mild’, ‘2’ for ‘moderate’, ‘3’ for ‘severe’, and ‘4’ for ‘life-
threatening’. The scales had been marked in accordance 
to the level of severity from the effects of chemotherapy. 
All the study tools were validated and used in both 
Malay and English language.
Data analysis
The data entered were analyzed using SPSS version 23. 
Mean and standard deviation (SD) respectively were 
used to describe the continuous data and independent 
variable. Independent sample T-test was used to analyze 
the means between two independent groups. One way 
ANOVA was used to test dependent and independent 
groups which had more than two category. The 
confidence interval (CI) was set at 95% and level of 
significance at p < 0.25. Multiple linear regression model 
was carried out to determine the significant predictors of 
quality of life. Level of significance was set at p < 0.05.
Ethics consideration 
Ethics approval was obtained from the Medical Research 
Ethics Committee (MREC) Malaysia and the Ethics 
Committee for Research Involving Human Subjects 
Universiti Putra Malaysia. Permission was also obtained 
from all ten state hospitals before commencement of 
the study. Consent form was taken from each patient 
participated in this study.
RESULTS
A total of 1333 were included in this study which makes 
the response rate 100%. According to Table 1, numbers 
of female patients were almost two times higher than 
males. Approximately half of the respondents were 
Malays (53.3%), followed by Chinese (27.2%), Indians 
(14.6%), and other (5.0%). There were more married 
patients (68.9 %) participated in this study compared 
to other marital status. The majority of the patients had 
primary education (58.4%). Most of the patients are 
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experienced pain during chemotherapy treatment. Some 
88.1% patients did not join any cancer support society 
and 78.6% patients were worried about adverse drug 
reaction due to chemotherapy cancer. Table II shows 
that 51.2% patients received high social support and 
38.0% patients had mild level of hopelessness was the 
highest in determining the quality of life in patients. 
Table I: Socio demographic characteristics among chemotherapy can-
cer patients (N=1333) 
Variables                                                  Frequency 
Percentages 
(%)
Age                                                                  
< 40                                                               181 13.6
41-60                                                           699 52.4
> 61                                                             453 34.0
Gender
Male 520 39.0
Female 813 61.0
Race
Malay 710 53.2
Chinese 362 27.2
Indian 195 14.6
Others   66   5.0
Marital  status
Married 918 68.8
Single 205 15.4
Divorced/Widowed 210 15.8
Education level
No formal education 157 11.8
Primary 779 58.4
Secondary and above/Diploma/University 397 29.8
Working  
Yes 771 57.8
No  562 42.2
Monthly income
No income 157 11.8
<1500 251 18.8
1501-3500 757 56.8
>3501 168 12.6
Cancer stage
Stage 1, 2, 3 854 64.1
Stage 4 479 35.9
Chemotherapy cycle
1st and 2nd cycle 1098 82.4
3rd and 4th cycle or more 235 17.6
Pain due to chemotherapy
Yes 768 57.6
No 565 42.4
Joined  cancer  support society
Yes 158 11.9
No 1175 88.1
Worried of adverse effect due to chemotherapy
Yes 1048 78.6
No 285 21.4
working (57.8%) where most of them were earning in 
the range of RM 1501- RM 3500 (56.8%). The majority 
cancer patients (64.1%) were having stage 1, 2 and 
3 cancer followed by 35.9% diagnosed with stage 
4 cancer. Most of the patients involved in this study 
were in their first and second cycle of chemotherapy 
which was 82.4%. There were 57.6% patients who 
Table II:  Social support and Hopelessness level among chemotherapy 
cancer patients (N=1333)
Variables                                                  Frequency  Percentages (%)
Social support
Low                  233 17.5
Medium                                                           417 31.3
High       683 51.2
Total 1333 100
Hopelessness level
None or Minimal 136 10.2
Mild 507 38.0
Moderate 412 30.9
Severe 278 20.9
Total 1333 100
Table III shows the summary of results for physical effect 
among chemotherapy cancer patients. The table shows 
the highest number of patients (51.5%) were affected 
due to mild skin nail changes during chemotherapy, 
followed by 49.0% affected with mild hair loss during 
chemotherapy. 
Table IV shows the mean of quality of life in cancer 
patients undergoing chemotherapy. The highest mean of 
quality of life was for the physical health domain 52.60 
(±19.94) followed by psychological domain 52.55 
(±21.44). The mean of overall quality of life shows 
3.51(±0.721).
Table V and VI shows that age, race, marital status, 
education level, working, monthly income, cancer 
stage and pain during chemotherapy, social support, 
hopelessness level, nausea, vomiting, fatigue and 
nail and skin changes were found to be statistically 
significant associated with all the domains of quality of 
life (physical health, psychological, social relationships 
and environment domain) among chemotherapy cancer 
patients (p<0.25). 
Association between social demographic characteristics 
and quality of life among chemotherapy cancer patients.
Patient more than 65 years old have reported the highest 
score for mean value in terms of quality of life in the 
psychological domain. Malay patients showed the 
highest mean score in the psychological domain, thus 
leading to a better quality of life. This study found that 
patients with single status had the highest mean score of 
quality of life in the psychological domain compared to 
married and divorced or widowed patients.
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Table III: Physical effects of chemotherapy among chemotherapy can-
cer patients (N=1333)
Variables                                                  Frequency  Percentage (%)
Nausea
None 560 42.0
Mild 380 28.5
Moderate 285 21.4
Severe 108   8.1
Vomiting
None 367 27.5
Mild 455 34.1
Moderate 381 28.6
Severe 130 9.8
Anorexia
None 354 26.6
Mild 454 34.1
Moderate 387 29.0
Severe 138 10.3
Diarrhea
None 313 23.5
Mild 377 28.3
Moderate 368 27.6
Severe 275 20.6
Constipation
None 523 39.2
Mild 335 25.1
Moderate 200 15.0
Severe 275 20.7
Anemia
None 266 20.0
Mild 363 27.2
Moderate 430 32.2
Severe 274 20.6
Fever
None 515 38.6
Mild 236 17.7
Moderate 305 22.9
Severe 277 20.8
Fatigue
None 146 11.0
Mild 322 24.1
Moderate 453 34.0
Severe 412 30.9
Infection
None 344 25.8
Mild 374 28.0
Moderate 394 29.6
Severe 221 16.6
Table III: Physical effects of chemotherapy among chemotherapy can-
cer patients (N=1333) (cont)
Variables                                                  Frequency  Percentage (%)
Bleeding
None 567 42.5
Mild 434 32.6
Moderate 219 16.4
Severe 113   8.5
Hair Loss
None 186 14.0
Mild 378 28.4
Moderate 654 49.0
Severe 115   8.6
Mouth gum Throat Infection
None 348 26.1
Mild 438 32.9
Moderate 254 19.0
Severe 293 22.0
Skin Nail Changes
None 458 34.4
Mild 687 51.5
Moderate 116   8.7
Severe 72   5.4
Table IV: Mean for quality of life among cancer patients receiving 
chemotherapy
Variable Physical 
health
Psycho-
logical
Social rela-
tionships
Environ-
ment 
Overall 
Quality of 
life
Mean 
(±SD)
52.60 
(19.94)
52.55 
(21.44)
50.79 
(20.94)
51.16 
(19.61)
3.51 
(0.721)
Education above secondary level was associated with the 
highest mean score of quality of life in the psychological 
domain compared to those with primary education and 
no formal education. This study suggests that employed 
chemotherapy patients had a better quality of life in 
the physical health domain and patients with monthly 
income exceeding RM3501 had a better quality of life in 
the psychological domain compared to chemotherapy 
cancer patients who were earning less. Cancer stage 1, 2 
and 3 and no pain during to chemotherapy in this study 
has reported highest mean score of quality of life in 
the psychological domain. Results showed that cancer 
patients with stage 1, 2 and 3 have a higher mean score 
of quality of life in psychological domain compared to 
those in stage 4.
Association between social support and quality of life 
among chemotherapy cancer patients
There were significant differences between social support 
and quality of life in chemotherapy cancer patients in 
all four domains (physical health, psychological, social 
relationships and environment). High social support was 
associated with the highest mean score of quality of life 
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Table V: Association between socio demographic characteristics, social support, hopelessness level and quality of life among chemotherapy 
cancer patients
Variables Physical health Psychological Social 
relationships 
Environment 
Mean(±SD) p Mean(±SD) p Mean(±SD) p Mean(±SD) p
Socio Demo-
graphic Profile
Age <45
45-54
>65
49.15(20.27)
52.90(18.65)
53.51(21.56)
0.04* 48.11(21.86)
53.00(20.24)
53.64(22.86)
0.010* 46.25(22.21)
52.43(19.80)
51.61(21.92)
0.01* 47.67(19.98)
51.59(18.57)
51.89(20.89)
0.040*
Gender Male 
Female
51.90(18.04)
53.05(21.06) 0.29
51.95(19.34)
52.94(22.69)
0.400 50.62(18.96)
50.90(22.12)
0.81 50.80(18.21)
51.39(20.47)
0.590
Race Malay 
Chinese
Indian
Others
53.71(20.23)
51.85(18.92)
51.27(20.16)
48.64(21.03)
0.10*
53.80(21.95)
52.21(20.09
50.61(21.46)
46.85(22.12)
0.030* 51.55(21.27)
51.33(19.74)
49.38(20.80)
43.82(22.98)
0.03* 51.68(19.83)
51.52(18.58)
50.24(19.95)
46.22(21.36)
0.160*
Marital status Single
Married
Divorced/Wid-
owed
58.50(21.40)
51.56(19.65)
51.21(18.65)
<0.001** 58.65(24.19)
51.43(21.05)
51.36(19.10)
<0.001** 54.42(24.53)
50.09(20.45)
50.18(18.69)
0.02* 55.42(21.97)
50.32(19.22)
50.55(18.30)
0.003*
Education 
level 
No formal 
education
Primary  
Secondary and 
above /Diplo-
ma/University
47.68(18.81)
51.35(18.78)
57.00(21.75)
<0.001** 47.45(18.62)
51.22(19.98)
57.19(24.30)
<0.001** 47.19(18.82)
50.15(19.67)
53.46(23.70)
0.003* 47.15(18.02)
50.37(18.62)
54.30(21.62)
<0.001**
Working Yes
No
54.47(20.86)
50.59(18.43)
<0.001** 54.07(22.43)
49.93(19.73)
<0.001** 52.06(21.80)
49.05(19.57)
0.010* 52.37(20.49)
49.50(18.22)
0.007*
Monthly in-
come
<1500
1500-3500
>3501
55.90(19.47)
51.06(19.61)
56.02(21.42)
<0.001** 54.94(23.23)
51.37(20.50)
55.43(23.18)
0.012* 53.42(21.26)
49.75(20.34)
53.54(23.19)
0.024* 53.44(20.70)
50.09(19.07)
53.59(20.46)
0.010*
Cancer profile
Cancer stage 1,2,3
4
54.17(20.51)
49.78(18.57)
<0.001** 54.26(22.25)
49.51(19.56)
<0.001** 51.79(21.62)
49.01(19.56)
0.02* 52.48(20.27)
48.81(18.17)
0.010*
Chemotherapy 
cycle
1,2
3,4 or more
52.86(20.29)
51.39(18.20)
0.270 52.57(21.79)
52.47(19.80)
0.950 50.67(21.15)
51.36(19.95)
0.650 51.22(19.86)
50.86(18.33)
0.68
Pain during 
chemotherapy
Yes
No
51.05(18.82)
54.70(21.20)
<0.001** 50.95(19.53)
54.73(23.64)
0.002* 50.42(18.46)
50.98(21.05)
0.130* 50.42(18.46)
52.16(21.05)
0.120*
Cancer 
support***
Yes
No
51.54(19.47)
52.74(20.01)
0.480 50.75(20.27)
52.80(21.59)
0.260 49.41(19.83)
50.97(19.54)
0.380 49.72(18.98)
51.35(19.70)
0.310
Worried of 
adverse effect 
due to chemo-
therapy*
Yes
No
52.90(20.09)
51.55(19.37)
0.310 52.59(21.78)
52.46(20.23)
0.920 50.70(21.32)
51.16(21.21)
0.730 51.16(19.86)
51.21(18.75)
0.970
Social support Low 
Medium 
High
46.21(17.94)
51.12(19.91)
55.67(20.01)
<0.001** 45.39(20.06)
52.53(20.07)
55.41(22.12)
<0.001** 45.50(19.00)
49.70(20.71)
53.26(21.33)
<0.001** 44.89(18.31)
50.94(19.32)
53.43(19.77)
<0.001**
Hopelessness 
level
None/minimal
Mild 
Moderate 
Severe 
58.93(22.90)
54.22(18.76)
50.30(20.41)
49.95(18.86)
<0.001** 58.74(24.61)
54.43(21.12)
50.92(20.68)
48.53(20.53)
<0.001** 55.18(24.67)
52.50(19.86)
49.17(21.36)
47.93(19.67)
<0.001** 55.44(22.30)
52.74(19.21)
50.42(19.31)
47.27(18.71)
<0.001**
*p < 0.25 significant ,**p < 0.001 significant, ***T-test
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Table VI: Association between physical effects of chemotherapy and quality of life among chemotherapy cancer patients
Variables Physical 
health 
Psychological Social relation-
ships 
Environment 
Mean(±SD) p Mean(±SD p Mean(±SD p Mean(±SD p
Physical effects of 
chemotherapy 
Nausea Yes 
No 
46.21(17.94)
51.12(19.91)
<0.001** 68.38(18.88)
41.09(14.89)
<0.001** 64.82(17.81)
40.63(16.74)
<0.001** 64.86(16.14)
41.23(15.50)
<0.001**
Vomiting Yes 
No
54.98(18.58)
51.69(20.37)
0.005* 55.15(20.78)
51.57(21.62)
0.006* 53.41(20.28)
49.80(21.20)
0.004* 53.70(18.57)
50.19(19.92)
0.003*
Anorexia Yes 
No
53.05(19.92)
52.43(19.95)
0.630 53.53(21.14)
52.20(21.55)
0.320 51.25(20.93)
50.62(20.95)
0.630 51.96(19.27)
50.87(1974)
0.370
Diarrhea Yes 
No
53.40(20.38)
52.35(19.80)
0.410 53.22(21.87)
52.35(21.31)
0.410 51.23(21.42)
50.65(20.79)
0.670 51.70(19.73)
50.99(19.58)
0.580
Constipation Yes 
No
52.05(20.34)
52.95(19.68)
0.320 51.82(21.56)
53.02(21.36)
0.320 50.35(21.29)
51.07(20.71)
0.540 50.54(19.67)
51.56(19.58)
0.360
Anemia Yes 
No
53.42(21.16)
52.39(19.63)
0.990 53.29(23.24)
52.37(20.98)
0.560 50.58(22.81)
50.84(20.45)
0.870 50.85(21.00)
51.24(19.26)
0.790
Fever Yes 
No
52.61(20.38)
52.59(19.67)
0.990 53.30(21.57)
52.08(21.36)
0.310 51.40(21.00)
50.91(19.62)
0.40 51.56(19.61)
50.91(19.62)
0.560
Fatigue Yes 
No
60.22(21.23)
51.66(19.58)
<0.001** 61.70(24.89)
51.43(20.71)
<0.001** 57.38(23.91)
49.98(20.40)
<0.001** 57.70(21.46)
50.35(19.23)
<0.001**
Infection Yes 
No
53.53(21.19)
52.27(19.48)
0.330 53.77(23.19)
52.13(20.79)
0.260 50.81(22.73)
50.78(20.28)
0.980 51.73(21.18)
50.96(19.04)
0.550
Bleeding Yes 
No
52.76(21.02)
52.48(19.90)
0.800 52.81(21.45)
52.36(21.45)
0.710 51.10(21.00)
50.56(20.90)
0.670 51.44(19.57)
50.95(19.66)
0.640
Hair Loss Yes 
No
52.09(18.47)
52.68(20.17)
0.710 52.42(20.82)
52.57(21.55)
0.930 50.78(19.60)
50.79(21.15)
1.000 50.95(19.03)
51.19(19.71)
1.000
Mouth throat 
infection
Yes 
No
53.53(20.43)
52.26(19.76)
0.300 53.51(22.25)
52.20(21.14)
0.330 50.99(21.92)
50.71(20.57)
0.830 51.58(20.33)
51.00(19.35)
0.640
Skin nails changes Yes
No
54.44(19.99)
51.63(19.86)
 * 0.030 54.42(22.17)
51.58(21.00)
0.020* 52.45(21.39)
49.92(20.65)
0.036* 52.81(19.68)
50.29(19.53)
0.030*
*p < 0.25 significant, **p < 0.001 significant, T-test
in the physical health domain. 
Association between hopelessness and quality of life 
among chemotherapy cancer patients.
There were significant differences relationship between 
hopelessness level and quality of life in chemotherapy 
cancer patients in all four domains (physical health, 
psychological, social relationships and environment). In 
this study, the mean of hopelessness in chemotherapy 
cancer patients was highest for the category of none 
or minimal feeling of hopelessness in physical health 
domain of quality of life.
Association between physical effects and quality of life 
among chemotherapy cancer patients.
In this study, the mean value of quality of life was found 
highest in patients who were not affected by nausea in 
the psychological domain of quality of life.  From the 
results of the study, significant differences can be seen 
between fatigue and quality of life in chemotherapy 
cancer patients in all domains (physical health, 
psychological, social relationship, and environment). 
There was a significant relationship between nail and 
skin and quality of life in chemotherapy cancer patients 
in all domains (physical health, psychological, social 
relationship, and environment), were observed in this 
study.
Predictors of quality of life
Using multiple regression analysis, there were five 
statistically significant predictors in physical health 
domain which were: monthly income, cancer stage, 
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social support, nausea and vomiting. In psychological 
domain there were five statistically significant predictors 
which were race, marital status, cancer stage, nausea 
and vomiting. In social relationships domain there were 
five statistically significant predictors which were: race, 
education level, social support, nausea and vomiting. 
In environment domain there were five statistically 
significant predictors: race, marital status, hopelessness 
level, nausea and vomiting. This can be seen in Table 
VII.
DISCUSSION
Cancer is a serious national health concern and, 
furthermore, it is becoming increasingly challenging to 
manage the affected cancer patient with the poor quality 
of life who needs more support and medical attention 
(8). Cancer can be prevented by ensuring healthy diet 
and activities. Not only that, early discovery of cancer 
can improve patient’s quality of life further increase 
the survival among them (8, 9). Patient more than 65 
years old have reported a better quality of life in the 
psychological domain in this study. This study shows 
older aged cancer patients were experiencing a better 
quality of life comparative to younger patients. Similar 
outcomes were reported by (10)Ganesh, Lye and Lau 
(2016) whereby those patients diagnosed with cancer 
and aged 55 years and above recorded an enhanced 
quality of life when compared to those younger cancer 
patients. The reason for such deteriorated quality of life 
portrayed among those below 55 years is the undue 
stress from much worry regarding income and career 
factors. Those elder patients may worry less regarding 
Table VII: Predictors of Quality of Life by Using Multiple Linear Regression Model
Physical health Psychological Social relationships Environment 
Variables B p B p B p B p
Socio demographics 
characteristics 
Race / / -5.34 0.01* -6.54 0.004* -4.29 0.037*
Marital status / / 2.63 0.04* 2.79 0.020*
Education level -2.30 0.040*
Monthly income 2.80 0.02* / / /
Cancer stage -2.18 0.02* -2.13 0.03* / /
Social support -2.97 0.006* -2.87 0.015*
Hopelessness  level / / / / / -3.97 0.004*
Physical effects 
Nausea -24.99 <0.001** -27.28 <0.001** -24.99 <0.001** -24.23 <0.001**
Vomiting  3.84 <0.001** 4.29 <0.001**  3.72 <0.001** 3.57 <0.001**
*p <0.05 significant, **p<0.001 significant, Multiple Linear regression
finance probably because of financial dependence from 
their children (10). Other studies reported conflicting 
association between age and quality of life. The results 
demonstrated that the improvement of quality of life 
among breast cancer patients decreased with age (11, 
12). 
In the United States and some European countries, 
studies show that ethnicity or race was found to be an 
important factor influencing the survival rate of patients 
(13, 14). Malay patients showed the highest mean score 
in the psychological domain, thus leading to a better 
quality of life in this study. This is similar to a study 
conducted by (15)Farooqui et al. (2013) where Malay 
patients showed a better quality of life with a higher 
score in global health. This result is also in line with 
(16)Harandy et al. (2010) which reported that Muslim 
Iranian breast cancer patients cope spiritually and 
religiously with their disease for their psychological 
well-being. In contrast, a review article reported that 
Indian respondents had the highest score for global 
health status followed by Malays, while the Chinese 
had the lowest score (17). However, when Malay and 
Chinese breast cancer survivors were compared, it was 
reported that the Malays had more symptoms of nausea, 
vomit, dyspnea, and constipation, thus translating to a 
poorer quality of life compared to Chinese women (18). 
In contrast to all the studies above, (19)Al-Naggar et 
al. (2009) reported no significant association between 
ethnicity and survival time of cancer patients. 
This study found that patients with single status had the 
highest mean score of quality of life in the psychological 
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domain compared to married and divorced or widowed 
patients. A similar outcome was shown in a study where 
single cancer women were also found to have a better 
quality of life compared to married women. This may 
be due to single women being less worried about the 
opinion of their partners (20). However, another study 
reported that married patients had a better physical 
functioning quality of life. This was also supported 
by another study in which married cancer survivors 
had higher physical health compared to single cancer 
patients (21). On the other hand, it was also reported 
that married women experienced better health-related 
quality of life and less fatigue compared to unmarried 
women (22). However, another group of scholars found 
otherwise; marital status was significant with quality of 
life where divorced patients had better global health 
scores (6).
Education above secondary level was associated with the 
highest mean score of quality of life in the psychological 
domain compared to those with primary education and 
no formal education. This finding is similar to that in a 
study by (23)Kwan et al. (2010) where more than 75% of 
their study subjects were reported to have at least high 
school education and above. This association between 
higher education and better quality of life might arise 
because better cancer knowledge can be obtained as the 
education level which contributes to early detection and 
treatment (21). Meanwhile, some other studies showed 
education had no effect on quality of life among cancer 
patients undergoing chemotherapy treatment (24, 25). 
Another study also mentioned education level was not 
significantly associated with quality of life although 
the global health score increased as education level 
increased (17). 
Employed chemotherapy patients had a better quality 
of life in the physical health domain in this study and 
patients with monthly income exceeding RM3501 had 
a better quality of life in the psychological domain 
compared to chemotherapy cancer patients who were 
earning less. The finding is consistent with that of other 
previous study where housewives had a poorer quality 
of life compared to employed cancer patients (25). 
(26)Guner et al. 2006 similarly reported that quality 
of life among cancer patients in Turkey was lower 
in low income patients. Cancer patients with high 
financial support displayed enhanced quality of life, 
in comparison to those with average and low financial 
positions (2). As a matter of fact, the aspect of earning 
capability has emerged as assurance to enhanced 
quality of life for cancer patients with chemotherapy as 
treatment (28). Moreover, according to (29)Yan et al. 
(2016), households with high income had been linked 
to enhanced quality of life in terms of all aspects among 
breast cancer patients. 
Cancer stage 1, 2 and 3 and no pain due to chemotherapy 
in this study has reported highest mean score of quality 
of life in the psychological domain. Results showed 
that cancer patients with stage 1, 2 and 3 have a higher 
mean of quality of life compared to those in stage 4. This 
is consistent with another study where results reported 
that stage 4 cancer patients had worse quality of life 
compared to stage 1 patients (10). Another study also 
reported that patients with bone cancer at very advanced 
stage showed the lowest global health status scores (15). 
The quality of life scores are significantly associated 
with the site of cancer, stage of cancer, and the time 
starting from the diagnosis of the disease (27). Emotional, 
cognitive and social functions were higher in the early 
stage of cancer among colorectal cancer patients (30). 
However, the same study mentioned that there was no 
significant association between global health status and 
stages of cancer even though the health status of stage 2 
and 3 patients was better than in stage 4 patients. 
High social support was associated with the highest 
mean score of quality of life in the physical health 
domain.  Studies also have proven that social support 
received from parents, friends, and healthcare providers 
is the most important resource for adults with cancer 
(31, 32). (24)Gunes et al. (2016) also reported that social 
support received by chemotherapy cancer patients from 
family members can improve their quality of life. Social 
support and cancer progression are closely related to 
each other. Low social support can cause poor health 
outcomes in cancer patients, which further decreases 
their quality of life (33, 34). A positive correlation was 
found between social support and health-related quality 
of life in breast cancer patients (35). Therefore higher 
social support results in a higher score of quality of life 
for cancer patients.
In this study, the mean score of hopelessness in 
chemotherapy cancer patients was highest for the 
category of none or minimal feeling of hopelessness in 
physical health domain of quality of life. The feeling of 
hopelessness was significantly associated with quality of 
life in chemotherapy cancer patients. Past studies showed 
that the coping strategy toward the disease is associated 
with quality of life and hopelessness in chemotherapy 
cancer patients (36). Another study reported that married 
patients had a higher score for hopelessness compared 
to single patients and also illiterate patients have a higher 
mean value of hopelessness than educated patients (28). 
Basically, quality of life of cancer patients is significantly 
impacted by hopelessness (28). 
Mean value of quality of life was found highest in 
patients who were not affected by nausea in the 
psychological domain of quality of life.  A similar study 
also supported this finding where chemotherapy patients 
who were experiencing nausea and vomiting during 
treatment reported having a negative impact on their 
daily quality of life (37). In a prospective study, results 
showed that symptoms such as loss of appetite, nausea, 
and vomiting had negative effects on the quality of life 
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among cancer patients (28). Nausea and vomiting which 
are not managed in chemotherapy cancer patients cause 
major weight loss and loss of appetite which leads to 
malnutrition in patients (28).
Fatigue is one of the symptoms that trigger emotional 
pressure among cancer patients (38). Significant 
differences can be deduced between fatigue and quality 
of life in chemotherapy cancer patients in all domains 
(physical health, psychological, social relationship, 
and environment). According to a study, fatigue was 
the main factor affecting the quality of life in colorectal 
cancer patients. The study also stated that fatigue during 
chemotherapy was reduced after the chemotherapy 
cycle was completed (39). Female cancer patients 
experienced worse fatigue symptoms compared to male 
patients, causing them to have a poorer quality of life. 
It could be that cancer has a bigger impact on women 
both physically and mentally, thus producing more 
symptoms (17). Cancer patients suffer side effects such 
as fatigue, which not only decreases quality of life but 
also shortens lifespan (8).
Significant changes on nail and skin, as well as its 
association with quality of life in chemotherapy cancer 
patients in all domains (physical health, psychological, 
social relationship, and environment), were observed in 
this study. Significant association on changes to patient’s 
nail and skin because of cancer chemotherapy was 
reported in a study where patient’s quality of life can 
be negatively affected due to toxic effects on nail and 
skin leading to treatment interruption or discontinuation 
(40, 41). Chemotherapy treatment can cause various 
types of nail changes among cancer patients. Hence 
knowledge of various changes of nail among patients 
undergoing chemotherapy is vital for successful patient 
management (42). 
The strength of this study is the sample size was large. 
There are not many studies published on quality of life 
among cancer patients undergoing chemotherapy in 
Malaysia. The findings of this study can further help 
future researchers to adequately identify the specific 
needs of each chemotherapy cancer patient. This study 
shows the importance for health professionals to be 
aware of the aspects that may affect quality of life of 
chemotherapy cancer patients. Among the limitations of 
this study are time and financial constraint as well as this 
study was limited to Peninsular Malaysia state hospitals 
only. However, the findings of this current study can 
still provide a baseline understanding of quality of life 
among cancer patients undergoing chemotherapy in 
government hospitals in Malaysia.
CONCLUSION
As found in this study, each of the four domains of 
quality of life had various predictors; such as monthly 
income, cancer stage, social support (physical health 
domain), race, marital status, cancer stage (psychological 
domain), race, education level, social support (social 
relationships domain), and race, marital status, 
hopelessness (environment domain). There were also 
similar predictors of all domains of quality of life which 
were nausea and vomiting. These predictors provide 
an indication on what factors need to be improved and 
treated adequately in order to improve the overall quality 
of life and also each specific domain of quality of life of 
cancer patients undergoing chemotherapy. It is hoped 
that by improving the quality of life of these patients, 
the adherence and outcome to treatment also improves, 
and this subsequently improves the prognosis and 
survival rate of each patient. Future studies can include 
developing intervention programs to improve the quality 
of life of cancer patients undergoing chemotherapy.
ACKNOWLEDGEMENT
The authors thank the Director General of Health 
Malaysia for his permission to publish this article. We 
would also like to thank the hospitals and participants 
involved in the study.
REFERENCES
1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, 
Mathers C, Rebelo M, et al. Cancer Incidence 
and Mortality Worldwide: IARC CancerBase No. 
11. International Agency for Research on Cancer. 
2013. Extracted from: http://globocan.iarc.fr/Pages/
references.aspx
2. Xiao C, Miller AH, Felger J, Mister D, Liu T, Torres 
MA. A prospective study of quality of life in breast 
cancer patients undergoing radiation therapy. 
Advances in Radiation Oncology. 2016;1(1):10-
16.
3. Manan AA, Tamin NSI, Abdullah NH, Abidin AZ, 
Wahab M. Malaysian National Cancer Registry 
Report 2007-2011. National Cancer Institute 
(NCI). 2016. Retrived from: https://www.crc.
gov.my/wp-content/uploads/documents/ report/
MNCRRrepor2007-2011.pdf
4. NCI. Types of Cancer Treatment. Natonal Cancer 
Institute (NCI). 2017. Retrieved from: https://www.
cancer.gov/about-cancer/treatment/types
5. Yan B, Yang LM, Hao LP, Yang C, Quan L, Wang 
LH, et al. Determinants of Quality of Life for Breast 
Cancer Patients in Shanghai, China. Journal Plos 
One. 2016;11(4):1-14. doi:10.1371/journal.
pone.0153714.
6. Dehkordi A, Heydarnejad MS, Fatehi D. Quality of 
Life in Cancer Patients undergoing Chemotherapy. 
Oman Medical Journal. 2009;24(3):204-207.
7. WHO. Cancer. World Health Organization. 2017. 
Retrieved from: http://www.who.int/mediacentre/
factsheets/fs297/en/
8. Ezat WPS, Noraziani K, Sabrizan O. Improving 
Quality of Life Among Cancer Patients in Malaysia. 
Mal J Med Health Sci 15(1): 5-15, Jan 201914
Malaysian Journal of Medicine and Health Sciences (eISSN 2636-9346)
Asian Pacific Journal of Cancer Prevention. 
2012;13(3):1069-1075.
9. Rowland JH, Mariotto A, Alfano CM. 
Survivors:United States, 2007. Morbidity and 
Mortality Weekly Report. Centers for Disease 
Control and Prevention. 2011;60(9):269-272. 
Retrived from : https://www.cdc.gov/mmwr/
preview/mmwrhtml/mm6009a1.htm
10. Ganesh S, Lye MS, Lau FN. Quality of Life among 
Breast Cancer Patients In Malaysia. Asian Pac J 
Cancer Prev. 2016; 17(4):1677-84. doi: http://
dx.doi.org/10.7314/APJCP.2016.17.4.1677.
11. Benton MJ, Schlairet MC, Gibson DR. Change 
in quality of life among breast cancer survivors 
after resistance training: is there an effect of age? J 
Aging Phys Act. 2014;22(2):178–85. doi:10.1123/
japa.2012-0227.
12. Morrow P, Broxson A, Munsell M, Basen-Enquist 
K, Rosenblum C, Schover L, et al. Effect of age 
and race on quality of life in young breast cancer 
survivors. Clin Breast Cancer. 2014;14(2):21–31. 
doi:10.1016/j.clbc.2013.10.003.
13. Maskarinec G, Sen C, Koga K, Shannon M. Ethnic 
differences in breast cancer survival: status and 
determinants. Womens Health (Lond Engl). 
2011;7(6):677–687. doi:  10.2217/whe.11.67.
14. Ooi SL, Martinez ME, Li CI. Disparities in Breast 
Cancer Characteristics and Outcomes by Race/
Ethnicity. Breast Cancer Res Treat. 2011;127(3). 
doi:10.1007/s10549-010-1191-6.
15. Farooqui M, Hassali MA, Knight A, Akmal A, Saleem 
F, Farooqui MA, et al. Cross sectional assessment 
of Health Related Quality of Life (HRQoL) among 
patients with cancer in Malaysia. Asian Pacific 
Journal. 2013;14(5):3017–3021. doi:http://dx.doi.
org/10.7314/APJCP.2013.14.5.3017.
16. Harandy TF, Ghofranipour F, Montazeri A, 
Anoosheh M, Bazargan M, Mohammadi E, et al. 
Muslim breast cancer survivor spirituality: coping 
strategy or health seeking behavior hindrance? 
Health Care Women Int. 2010;31(1):88-98. 
doi:10.1080/07399330903104516.
17. Natrah MS, Ezat SW, Syed M, Rizal AM, Saperi 
S. Quality of Life in Malaysian Colorectal Cancer 
Patients : A Preliminary Result. Asian Pacific Journal 
of Cancer Prevention. 2012;13:957-962. doi:http://
dx.doi.org/10.7314/APJCP.2012.13.3.95.
18. Yusuf A, Hadi IS, Mahamood Z, Ahmad Z, Keng 
SL. Quality of life in Malay and Chinese women 
newly diagnosed with breast cancer in Kelantan, 
Malaysia. Asian Pacific Journal of Cancer 
Prevention. 2013; 14(1):435–440.
19. Al-Naggar RA, Isa ZM, Azhar S, Nor MI, Chen R, 
Ismail F, Radman SA. Eight year survival among 
breast cancer Malaysian women from University 
Kebangsaan Malaysia Medical Centre. Asian Pac J 
Cancer Prev. 2009;1075-1078.
20. Jassim GA, Whitford DL. Quality of life of Bahraini 
women with breast cancer: a cross sectional 
study. BMC Cancer. 2013;13:212. https://doi.
org/10.1186/1471-2407-13-212
21. Ramadas A, Qureshi AM, Dominic NA, Botross NP, 
Riad A, Arasoo VJT, et al. Socio-Demography and 
Medical History as Predictors of Health-Related 
Quality of Life of Breast Cancer Survivors. Asian 
Pac J Cancer Prev. 2015;16(4):1479-1485. doi: 
http://dx.doi.org/10.7314/APJCP.2015. 16.4.1479.
22. Lua PL, Salihah NZ, Mazlan N. Nutritional Status 
and Health-Related Quality of Life of Breast 
Cancer Patients on Chemotherapy. Mal J Nutr. 
2012;18(2):173-184. doi:10.1186/s12885-017-
3336-z.
23. Kwan ML, Ergas IJ, Somkin CP, Quesenberry CP, 
Neugut AI, Hershman DL, et al. Quality of life 
among women recently diagnosed with invasive 
breast cancer: the Pathways Study. Breast Cancer 
Res Treat. 2010;123:507-24. doi:10.1532/
IJH97.07040.
24. Gunes Z, Calisır H. Quality of Life and Social 
Support in Cancer Patients Undergoing Outpatient 
Chemotherapy in Turkey. Annals of Nursing and 
Practice. 2016;3(7):1-5.
25. Velikova G, Awad N, Coles-Gale R, Wright 
EP, Brown JM, Selby PJT. The clinical value of 
quality of life assessment in oncology practice-a 
qualitative study of patient and physician views. 
Psychooncology. 2008;17(7):690-8.. doi: 
10.1053/j.seminhematol.2008.12.007.
26. Guner P, Isikhan V, Komurcu SIlS, Ozturk B, Arpaci 
F, Ozet A. Quality of life and sociodemographic 
characteristics of patients with cancer in Turkey. 
Oncol Nurs Forum. 
2006; 33(6):1171-6.
27. Pandey RA, Dhungana GP, Twi JT, Byanju S, 
Khawas B. Quality of Life of Patients Undergoing 
Cancer Treatment in B.P. Koirala Memorial Cancer 
Hospital, Bharatpur, Chitwan, Nepal. American 
Journal of Cancer Prevention. 2015;3(2):35-44. 
doi:10.12691/ajcp-3-2-3.
28. Sahin ZA, Tan M, Polat H. Hopelessness, 
Depression and Social Support with End of Life 
Turkish Cancer Patients. Asian Pacific Journal of 
Cancer Prevention. 2013;14(5):2823-2828.
29. Yan B, Yang LM, Hao LP, Yang C, Quan L, Wang 
LH, et al. Determinants of Quality of Life for Breast 
Cancer Patients in Shanghai, China. Journal Plos 
One. 2016;11(4):1-14. doi:10.1371/journal.
pone.0153714.
30. Puteh SEW,  Saad NM,  Aljunid SM, Manaf RA, 
Sulong S,  Sagap I, et al. Quality of life in Malaysian 
colorectal cancer patients. AsiaPacific Psychiatry. 
2013;5(S1):110-117. doi:10.1111/appy.12055.
31. Eom CS, Shin DW, Kim SY, Yang HK, Jo HS, 
Kweon SS, et al. Impact of perceived social support 
on the mental health and health-related quality of 
life in cancer patients: results from a nationwide, 
multicenter survey in South Korea. Psycho-
Oncology. 2013;22(6):1283-90. doi: 10.1002/
Mal J Med Health Sci 15(1): 5-15, Jan 2019 15
pon.3133.
32. Naseri N, Taleghani F. Social support in cancer 
patients referring to Sayed Al-Shohada Hospital. 
Iran J Nurs Midwifery Res. 2012;17(4):279–283. 
33. Nausheen B, Gidron Y, Peveler R, Moss-Morris R. 
Social support and cancer progression: A systematic 
review. J Psychosomatic Res. 2009;67:403-15. doi: 
10.1016/j.jpsychores.2008.12.012.
34. Ustundag S, Zencirci AD. Factors affecting the 
quality of life of cancer patients undergoing 
chemotherapy: A questionnaire study. Asia Pacific 
Journal of Oncology Nursing. 2015;2(1):17-25.
35. Filazoglu G, Griva K. Coping and social 
support and health related quality of life 
in women with breast cancer in Turkey. 
Psychol Health Med. 2008;13(5):559-73. doi: 
10.1080/13548500701767353.
36. Laarhoven HWV, Schilderman J, Bleijenberg G, 
Donders R, Vissers KC, Verhagen CA, et al.  Coping, 
Quality of Life, Depression, and Hopelessness in 
Cancer Patients in a Curative and Palliative, End-
of-Life Care Setting. Cancer Nurs. 2011;34(4):302-
14. doi: 10.1097/NCC.0b013e3181f9a040.
37. Gozzo TO, Moyses AM, Silva PR, Almeida AM. 
Nausea, vomiting and quality of life in women 
with breast cancer receiving chemotherapy. Rev. 
Gaucha Enferm. 2013;34(3):110-116. http://
dx.doi.org/10.1590/S1983-14472013000300014
38. Priscilla D, Hamidin A, Azhar MZ, Noorjan K, 
Salmiah MS, Bahariah K. The socio-demographic 
and clinical factors associated with quality of life 
among patients with haematological cancer in a 
large government hospital in Malaysia. Malaysian 
Journal of Medical Sciences. 2011;18(3), 49–56.
39. Mrabti H, Amzatziren M, ElGhissassi I, Bensouda 
Y, Berrada N, Abahssain H, et al. Quality of life of 
early stage colorectal cancer patients in Morocco. 
BMC Gastroenterology. 2016;16(131):1-10. 
doi:10.1186/s12876-016-0538-9.
40. Joshi SS, Ortiz S, Witherspoon JN, Rademaker A, 
West DP, Anderson R, et al. Effects of epidermal 
growth factor receptor inhibitor-induced 
dermatologic toxicities on quality of life. Cancer. 
2010;116(16):3916-23. doi:10.1002/cncr.25090.
41. Usta YY. Importance of Social Support in Cancer 
Patients. Asian Pacific Journal of Cancer Prevention. 
2012;13(8):3569-72.
42. Reddy PK, Prasad AL, Sumathy TK, Reddy RV. 
Nail changes in patients undergoing cancer 
chemotherapy. International Journal of Research 
in Dermatology. 2017;3(1):49-54. doi: 10.18203/
issn.2455-4529.IntJResDermatol20164785.
